Literature DB >> 16290941

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position.

Ken-ichi Yoshida1, Kiyoshi Nakayama, Noriko Kuru, Shozo Kobayashi, Masami Ohtsuka, Makoto Takemura, Kazuki Hoshino, Hiroko Kanda, Jason Z Zhang, Ving J Lee, William J Watkins.   

Abstract

A series of 4-oxo-4H-pyrido[1,2-a]pyrimidine derivatives, derivatized at the 2-position with carbon-linked substituents, were synthesized and evaluated for their ability to potentiate the activity of the fluoroquinolone levofloxacin (LVFX) and the anti-pseudomonas beta-lactam aztreonam (AZT) in Pseudomonas aeruginosa. Palladium-catalyzed cross-coupling methods were applied for the incorporation of aliphatic and aromatic substituents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290941     DOI: 10.1016/j.bmc.2005.10.043

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

Review 3.  The hydrophobic trap-the Achilles heel of RND efflux pumps.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Res Microbiol       Date:  2017-11-13       Impact factor: 3.992

Review 4.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

Review 5.  Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Curr Opin Microbiol       Date:  2016-05-24       Impact factor: 7.934

6.  Polyhalonitrobutadienes as Versatile Building Blocks for the Biotargeted Synthesis of Substituted N-Heterocyclic Compounds.

Authors:  Viktor A Zapol'skii; Ursula Bilitewski; Sören R Kupiec; Isabell Ramming; Dieter E Kaufmann
Journal:  Molecules       Date:  2020-06-21       Impact factor: 4.411

7.  Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.

Authors:  Timothy J Opperman; Steven M Kwasny; Hong-Suk Kim; Son T Nguyen; Chad Houseweart; Sanjay D'Souza; Graham C Walker; Norton P Peet; Hiroshi Nikaido; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

8.  Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.

Authors:  Momen Askoura; Walid Mottawea; Turki Abujamel; Ibrahim Taher
Journal:  Libyan J Med       Date:  2011-05-13       Impact factor: 1.657

9.  The intrinsic resistome of bacterial pathogens.

Authors:  Jorge Olivares; Alejandra Bernardini; Guillermo Garcia-Leon; Fernando Corona; Maria B Sanchez; Jose L Martinez
Journal:  Front Microbiol       Date:  2013-04-30       Impact factor: 5.640

10.  Chemistry of polyhalogenated nitrobutadienes, 10: Synthesis of highly functionalized heterocycles with a rigid 6-amino-3-azabicyclo[3.1.0]hexane moiety.

Authors:  Viktor A Zapol'skii; Jan C Namyslo; Armin de Meijere; Dieter E Kaufmann
Journal:  Beilstein J Org Chem       Date:  2012-04-23       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.